Downloads: 3 | Views: 278 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Study Papers | General Surgery | India | Volume 11 Issue 11, November 2022 | Popularity: 5.3 / 10
Hyperbilirubinemia in Liver Abscess at Tertiary Care Hospital, Bhavnagar: A Prospective Observational Study
Dr. Dinesh Valani, Dr. Rajan B Somani
Abstract: Aim: To study hyperbilirubinemia in liver abscess patients and its correlation with severity. Settings and design: prospective randomized controlled study. Methods and material: Randomized prospective study in all patients of liver abscess who presented with fever and/or abdominal pain was assessed and their clinical examination finding & biochemical investigation were recorded. Case were divided in two group, GROUP 1 S. Bilirubin >=1mg/dl and GROUP 2 S. Bilirubin <1mg/dl. All case of liver abscess started on broad spectrum antibiotic and response was recorded based on improvement in clinical findings, leukocytosis, liver function test and ultrasonography. Result: GROUP 1 have history of alcohol intake which was significant more than GROUP 2. leukocytosis was in GROUP 1 was significant higher than GROUP 2. In group 1 patient if ranged from 1.2 to 12 mg/dl and direct bilirubin was more than indirect bilirubin in most of patients. Hyperbilirubinemia was found to have positive correlation with size of abscess cavity. Serum alkaline phosphates, SGPT, SGOT was raised significant in group 1. size of cavity directly correlated with raised ALP level. Patients with hyperbilirubinemia have shown comparatively higher rate of complications than those with normal s.bilirubin Conclusions: Hyperbilirubinemia occurs frequently in cases of liver abscess which seems to obstructive in nature and it can be treated by surgical drainage of the abscess cavity.
Keywords: IVER Abscess, Hyperbilirubinemia, Obstructive, Jaundice
Edition: Volume 11 Issue 11, November 2022
Pages: 583 - 585
DOI: https://www.doi.org/10.21275/MR221108002617
Please Disable the Pop-Up Blocker of Web Browser
Verification Code will appear in 2 Seconds ... Wait